Segment and Related Information (Tables)

12 Months Ended

Dec. 31, 2025

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

The measures of segment loss or profit for of our single reportable segment were as follows (in thousands):

	Years Ended December 31,
	2025		2024		2023
Net revenues from external customers(1)	$	344,229	$	332,069	$	219,788
Significant segment expenses:
Personnel costs	209,816		189,883		172,248
Organizational and marketing costs	51,545		44,178		39,481
Inventory usage	21,821		19,930		15,475
Clinical studies and publication costs	8,777		9,951		11,924
Professional services	10,928		10,476		7,496
Other segment items	65,500		39,406		30,630
Segment (loss) profit	$	(24,158)	$	18,245	$	(57,466)

(1)For information on disaggregation of segment revenue by type and information about payor concentration, see Note 3.

Schedule of Other Segment Items

Other amounts included in the measure of segment loss or profit were as follows (in thousands):

	Years Ended December 31,
	2025		2024		2023
Interest income	$	11,772	$	12,916	$	10,623
Interest expense	$	86	$	577	$	11
Depreciation and amortization	$	40,771	$	15,997	$	12,330
Income tax (benefit) expense	$	(5,356)	$	3,319	$	101
Stock-based compensation expense	$	45,893	$	50,320	$	51,219
Net gains on equity securities	$	1,466	$	555	$	—